Quality by Design approaches to assessing the robustness of tangential flow filtration for MAb.

Multivariate analysis Process characterization Process robustness Quality by design (QbD) Tangential flow filtration (TFF)

Journal

Biologicals : journal of the International Association of Biological Standardization
ISSN: 1095-8320
Titre abrégé: Biologicals
Pays: England
ID NLM: 9004494

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 05 06 2019
revised: 06 12 2019
accepted: 07 12 2019
pubmed: 19 12 2019
medline: 22 10 2020
entrez: 19 12 2019
Statut: ppublish

Résumé

Quality by Design (QbD) is a modern approach for quality assurance in pharmaceutical production. This article illustrates a case study of TFF robustness performed for a process characterization of a monoclonal antibody under QbD principles by exploring functional relationships that link the process parameters to quality/process attributes with prior process knowledge, risk assessment, and multivariate experiments. In every case of quality or process attributes, all measured values were in alignment with the allowable specification range, and the developed models were non-significant and had no lack of fit, thus confirming the robustness of the TFF process within the tested ranges of process parameters.

Identifiants

pubmed: 31848036
pii: S1045-1056(19)30132-0
doi: 10.1016/j.biologicals.2019.12.001
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-61

Informations de copyright

Copyright © 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest This work was funded and supported by Dong-A Socio Holdings and Merck Ltd. Korea. Hyun Wee, EunJeong Bae and Taekyeol Lee are employees of Dong-A Socio Holdings and KeunHoe Koo is an employee of Merck Ltd. Korea.

Auteurs

Hyun Wee (H)

Biologics Process 1, Biologics Research Laboratories, Dong-A Socio Holdings R&D Center, Yongin, 17073, South Korea. Electronic address: hyunwee@donga.co.kr.

KeunHoe Koo (K)

Merck Ltd. Korea, 24 Fl., Bldg M, Songdo Technopark IT Center, Incheon, 21984, South Korea.

EunJeong Bae (E)

Biologics Process 1, Biologics Research Laboratories, Dong-A Socio Holdings R&D Center, Yongin, 17073, South Korea.

TaekYeol Lee (T)

Biologics Process 1, Biologics Research Laboratories, Dong-A Socio Holdings R&D Center, Yongin, 17073, South Korea; Department of Life Science, Sogang University, Seoul, South Korea.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
1.00
Iran Environmental Monitoring Seasons Ecosystem Forests
Cities China Government Conservation of Natural Resources Humans
Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female

Classifications MeSH